Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes mellitus and obesity
Manufactured to meet stringent quality control standards.
Available in bulk quantities to meet global demands.
Adheres to US FDA, EMA, and WHO-GMP guidelines.
Product application
• Treatment of type 2 diabetes mellitus • Management of obesity and weight loss therapy • Research & development in metabolic disorders
Connect to Explore More
Liraglutide is a long-acting GLP-1 analog designed for the management of type 2 diabetes and reduction of cardiovascular risk. Our engineered, yeast-derived version is in the preclinical stage, showcasing potential for enhanced stability and cost-effective production.
Key Benifits
• State-of-the-Art Manufacturing: Advanced biopharmaceutical production facility.
• Stringent Quality Control: In-depth analysis to ensure product consistency.
• Reliable Supply Chain: Efficient logistics for seamless global distribution.
• Expert Support: Technical and regulatory assistance available.
Specifications
• Chemical Name: Semaglutide
• Molecular Formula: C187H291N45O59
• Molecular Weight: 4113.64 g/mol
• Appearance: White to off-white powder
• Storage Conditions: Store at -20°C for long-term stability
Why Choose Us?
• Advanced Peptide Synthesis - Cutting-edge technology ensures consistent quality.
• Regulatory Support - Comprehensive documentation for DMF and regulatory submissions.
• Reliable Supply Chain - Ensuring timely delivery across global markets.
OUR TRUSTED PARTNERS
Empowering discovery through effective partnerships
Lorven biologics
Innovating today for a better tomorrow
Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.
Based in Hyderabad, IN
© 2025 Lorven Biologics. All Rights Reserved.
Empowering Science, Enriching Lives.
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes mellitus and obesity
Manufactured to meet stringent quality control standards.
Available in bulk quantities to meet global demands.
Adheres to US FDA, EMA, and WHO-GMP guidelines.
Product application
• Treatment of type 2 diabetes mellitus • Management of obesity and weight loss therapy • Research & development in metabolic disorders
Connect to Explore More
Liraglutide is a long-acting GLP-1 analog designed for the management of type 2 diabetes and reduction of cardiovascular risk. Our engineered, yeast-derived version is in the preclinical stage, showcasing potential for enhanced stability and cost-effective production.
Key Benifits
• State-of-the-Art Manufacturing: Advanced biopharmaceutical production facility.
• Stringent Quality Control: In-depth analysis to ensure product consistency.
• Reliable Supply Chain: Efficient logistics for seamless global distribution.
• Expert Support: Technical and regulatory assistance available.
Specifications
• Chemical Name: Semaglutide
• Molecular Formula: C187H291N45O59
• Molecular Weight: 4113.64 g/mol
• Appearance: White to off-white powder
• Storage Conditions: Store at -20°C for long-term stability
Why Choose Us?
• Advanced Peptide Synthesis - Cutting-edge technology ensures consistent quality.
• Regulatory Support - Comprehensive documentation for DMF and regulatory submissions.
• Reliable Supply Chain - Ensuring timely delivery across global markets.
OUR TRUSTED PARTNERS
Empowering discovery through effective partnerships
Lorven biologics
Innovating today for a better tomorrow
Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.
Based in Hyderabad, IN
© 2025 Lorven Biologics. All Rights Reserved.
Empowering Science, Enriching Lives.
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes mellitus and obesity
Manufactured to meet stringent quality control standards.
Available in bulk quantities to meet global demands.
Adheres to US FDA, EMA, and WHO-GMP guidelines.
Product application
• Treatment of type 2 diabetes mellitus • Management of obesity and weight loss therapy • Research & development in metabolic disorders
Connect to Explore More
Liraglutide is a long-acting GLP-1 analog designed for the management of type 2 diabetes and reduction of cardiovascular risk. Our engineered, yeast-derived version is in the preclinical stage, showcasing potential for enhanced stability and cost-effective production.
Key Benifits
• State-of-the-Art Manufacturing: Advanced biopharmaceutical production facility.
• Stringent Quality Control: In-depth analysis to ensure product consistency.
• Reliable Supply Chain: Efficient logistics for seamless global distribution.
• Expert Support: Technical and regulatory assistance available.
Specifications
• Chemical Name: Semaglutide
• Molecular Formula: C187H291N45O59
• Molecular Weight: 4113.64 g/mol
• Appearance: White to off-white powder
• Storage Conditions: Store at -20°C for long-term stability
Why Choose Us?
• Advanced Peptide Synthesis - Cutting-edge technology ensures consistent quality.
• Regulatory Support - Comprehensive documentation for DMF and regulatory submissions.
• Reliable Supply Chain - Ensuring timely delivery across global markets.
OUR TRUSTED PARTNERS
Empowering discovery through effective partnerships
Lorven biologics
Innovating today for a better tomorrow
Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.
Based in Hyderabad, IN
© 2025 Lorven Biologics. All Rights Reserved.
Empowering Science, Enriching Lives.